According to previous reports on anti-MDA5 antibody-negative patients with myositis-associated ILD, the cumulative survival rate over 5 years was >80%, regardless of the initial immunosuppressive regimen (12, 37–39). This evidence concerns the gene IFIH1 and myositis disease.